Now we also have naked short selling. 🙄 Their CFO would love that idea if the company was actually making any money since Mexedia holds all the preferred shares representing 75% ownership of the Mexedia Telvantis holding company. Exactly how would paying a dividend to preferred shareholders effect the lowly common share holders? 🤔 If there were those holding short they certainly wouldn't be too concerned with millions of dollars of currently eligible conversions, a 6.7 billion share structure, a reg A offering qualified by the SEC which will require the reverse split to make it viable. Brilliant! 😆 When the post below was written in January the reg A was priced at $0.003. Now the $1.5 million reg A is priced at $0.001.
...This merger agreement turned Raadr, now Telvantis, into a simple holding company of which Mexedia owns 75% of through the series F preferred shares handed over for nothing in the merger agreement. It doesn't work however unless they can con OTC retail into buying the regulation A offering shares. How do they make the $4.5 million priced at $0.003 offering viable? Amended price maybe, reverse split? We share see. One thing is for certain, they are desperate to get those shares sold. Watch for more misinformation to come in both the press releases and this board....